Improved efficacy of allergen-specific immunotherapy by JAK inhibition in a murine model of allergic asthma-Reference-Cited by-同舟云学术

Improved efficacy of allergen-specific immunotherapy by JAK inhibition in a murine model of allergic asthma

Published:2017-06-01 Issue:6 Volume:12 Page:e0178563
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Aguilar-Pimentel Antonio,Graessel Anke,Alessandrini Francesca,Fuchs Helmut,Gailus-Durner Valerie,Hrabě de Angelis Martin,Russkamp Dennis,Chaker Adam,Ollert Markus,Blank Simon^ORCID,Gutermuth Jan,Schmidt-Weber Carsten B.

Funder

German Federal Ministry of Education and Research

Translational and Clinical Projects Fund of the Helmholtz Center Munich

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference42 articles.

1. Injection allergen immunotherapy for asthma;MJ Abramson;The Cochrane database of systematic reviews,2010

2. Allergen injection immunotherapy for seasonal allergic rhinitis;MA Calderon;The Cochrane database of systematic reviews,2007

3. Long-term efficacy of allergen immunotherapy: what do we expect?;F Frati;Immunotherapy,2013

4. Allergen-specific immunotherapy;W Moote;Allergy, asthma, and clinical immunology: official journal of the Canadian Society of Allergy and Clinical Immunology,2011

5. Guidelines for treatment of atopic eczema (atopic dermatitis) Part II;J Ring;Journal of the European Academy of Dermatology and Venereology: JEADV,2012

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Activation of the aryl hydrocarbon receptor improves allergen-specific immunotherapy of murine allergic airway inflammation: a novel adjuvant option?;Frontiers in Immunology;2024-06-10

2. Future Directions of Allergen Immunotherapy for Allergic Rhinitis: Experts’ Perspective;The Journal of Allergy and Clinical Immunology: In Practice;2024-01

3. Not just another klass (JAK) of inhibitors for allergies;Journal of Allergy and Hypersensitivity Diseases;2024-01

4. Aeroallergen-specific Immunotherapy and Biologics Co-administration: Cost-benefit Re-considerations are Urgently Needed;Recent Advances in Inflammation & Allergy Drug Discovery;2023-09

5. CXC Chemokines in the Pathogenesis of Pulmonary Disease and Pharmacological Relevance;International Journal of Inflammation;2022-09-17